| 6.95 Delayed Data As of Jul 18 |  -0.46 / -6.21%Today’s Change | 3.90 Today|||52-Week Range 12.53 | +40.12% Year-to-Date |
| Previous close | 7.41 |
| Today’s open | 7.31 |
| Day’s range | 6.92 - 7.34 |
| Volume | 17,939,932 |
| Average volume (3 months) | 20,198,327 |
| Market cap | $6.9B |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +219.06% |
| P/E ratio | NM |
| Price/Sales | 76.68 |
| Price/Book | 3.24 |
| Today’s change | Today’s % change | |
|---|---|---|
| ARGXargenx SE | +1.73 | +1.16% |
| CRONCronos Group Inc | -0.03 | -0.20% |
| APHAAphria Inc | -0.11 | -1.68% |
| USNAUSANA Health Science... | +2.11 | +3.49% |
| Next reporting date | September 24, 2019 |
| EPS forecast (this quarter) | -$0.03 |
| Annual revenue (last year) | $43.5M |
| Annual profit (last year) | $56.6M |
| Net profit margin | 130.33% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer & Director Terry Booth |
President & Director Steve Dobler |
Corporate headquarters Edmonton, Alberta |
